MEI Pharma, Inc. MEIP saw a big move last session, as the company's shares fell more than 5.0% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session This reverses the recent trend for MEIP as the stock is now up around 17.2% in the past one-month time frame.
The company has seen a flat track record when it comes to current year estimate revisions over the past few weeks. The consensus for earnings hasn't been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.
MEIP currently has a Zacks Rank #4 (Sell) while its Earnings ESP is zero.
Some better-ranked stocks in the healthcare sector include Lannett Company, Inc. LCI, Questcor Pharmaceuticals, Inc. QCOR and Shire plc SHPG. All these stocks carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
The company has seen a flat track record when it comes to current year estimate revisions over the past few weeks. The consensus for earnings hasn't been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.
MEIP currently has a Zacks Rank #4 (Sell) while its Earnings ESP is zero.
Some better-ranked stocks in the healthcare sector include Lannett Company, Inc. LCI, Questcor Pharmaceuticals, Inc. QCOR and Shire plc SHPG. All these stocks carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
LANNETT INC LCI: Free Stock Analysis Report
MEI PHARMA INC MEIP: Free Stock Analysis Report
QUESTCOR PHARMA QCOR: Free Stock Analysis Report
SHIRE PLC-ADR SHPG: Free Stock Analysis Report
To read this article on Zacks.com click here.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
